Outstanding 12-month First-in-human Data from Xeltis’ aXess Hemodialysis Vascular Conduit Trial Presented at VEITHsymposium 2023news2023-11-17T15:12:20+00:00November 17th, 2023|Medical Device News Magazine|
Humacyte Announces Two Presentations at the VEITHsymposium of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular Traumanews2023-11-17T15:07:57+00:00November 17th, 2023|Medical Device News Magazine|
Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Daynews2023-11-17T00:01:49+00:00November 17th, 2023|Medical Device News Magazine|
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposiumnews2023-11-16T15:29:30+00:00November 16th, 2023|Medical Device News Magazine|
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITHsymposium on November 15news2023-11-09T18:18:03+00:00November 9th, 2023|Medical Device News Magazine|
Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trialsnews2023-11-08T10:32:31+00:00November 8th, 2023|Medical Device News Magazine|
NICO Corporation: Study Shows First-Ever Successful Deep-Brain Implant of Computer Chip in Living Animalnews2023-11-01T19:44:46+00:00November 1st, 2023|Medical Device News Magazine|
TCI Unveils Revolutionary Weight Loss Formula at SupplySide West 2023 – Human Trials Showcase Remarkable Effectiveness in Just 14 Days!news2023-10-31T09:21:31+00:00October 31st, 2023|Medical Device News Magazine|
TCT 2023: Six-Month Clinical Data from DESyne® BDS Plus Randomized Controlled Trial (RCT) Support Safety and Effectiveness of World’s First Site-Specific Antithrombotic Drug Therapynews2023-10-25T17:03:48+00:00October 25th, 2023|Medical Device News Magazine|
Annexin Pharmaceuticals Reports First Patient Treated in the Second Dose Group in Annexin’s RVO Studynews2023-10-25T09:00:54+00:00October 25th, 2023|Medical Device News Magazine|
